Meeting
2020 Genitourinary Cancers Symposium
Incorporating mpMRI and biomarkers in active surveillance protocols: The prospective Stockholm3 Active Surveillance trial (STHLM3AS).
Authors
Anna Lantz
Karolinska Institute, Uppsala, Sweden
Anna Lantz , Henrik Olsson , Tobias Nordström , Fredrik Jäderling , Lars Egevad , Magnus Annerstedt , Henrik Gronberg , Martin Eklund
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Trials in Progress Poster Session
Session Title
Trials in Progress Poster Session A: Prostate Cancer
Track
Prostate Cancer - Advanced,Prostate Cancer - Localized
Sub Track
Imaging
Clinical Trial Registration Number
NCTNCT03956108
Citation
J Clin Oncol 38, 2020 (suppl 6; abstr TPS379)
Abstract #
TPS379
Poster Bd #
P21
Abstract Disclosures
Similar Posters
Poster
2017 Genitourinary Cancers Symposium
Comparison of multiparametric MRI to PSA kinetics as an indication of prostate cancer progression in men on active surveillance.
First Author: Mahir Maruf
Poster
2014 ASCO Annual Meeting
Evaluation of the prostate health index (PHI) as a novel biomarker in active surveillance of prostate cancer.
First Author: Andrew Eichholz
Poster
2014 ASCO Annual Meeting
Role of serum lipids and glucose as biomarkers of prostate cancer severity.
First Author: Alejo Rodriguez-Vida
Poster
2014 Genitourinary Cancers Symposium
Evaluation of the prostate health index (phi) as a novel biomarker in active surveillance of prostate cancer.
First Author: Andrew Eichholz